ROME III criteria

ROME III criteria

Criteria which are used to diagnose irritable bowel syndrome.
Symptoms of recurrent abdominal pain or discomfort and a marked change in bowel habit for at least 6 months, with symptoms on at least 3 days for at least three months, and 2 or more of the following:
• Pain is relieved by a bowel movement;
• Pain onset linked to a change in frequency of stool;
• Pain onset linked to a change in appearance of stool.
References in periodicals archive ?
It is defined in Rome III criteria as one of three symptoms for last 3 months within the initial six month of symptoms onset of including; 1) postprandial fullness, 2) early satiety, and 3) epigastric pain or burning2.
ROME III criteria was used for the diagnosis of IBS and to assess GAD, a 7-item Generalized Anxiety Disorder (GAD-7) scale was used.
The diagnosis of IBS was based on the Rome III criteria.
T3MPO-1 was the company's 12-week, double-blind, placebo-controlled, multi-centre, randomized trial with a four-week, randomized withdrawal period conducted in a total of 610 patients meeting the ROME III criteria for the diagnosis of IBS-C.
The investigators randomized 92 adults meeting Rome III criteria for diarrhea-predominant IBS to follow either a low-FODMAP diet or a control diet that was based on recommendations from the National Institute for Health Care and Excellence (NICE, in the United Kingdom).
Mirtazapine did not significantly improve the other Rome III criteria for functional dyspepsia, but general overall score was significantly lower than for the control group.
In total, 75 adult patients meeting the Rome III criteria for IBS, with medium to severe symptoms based on an IBS Symptom Severity Score (IBS-SSS), were recruited from gastroenterology outpatient clinics in Sweden for inclusion in this multi-centre, parallel, randomised, controlled, single-blind, comparative trial.
Nonetheless, IBS is not a diagnosis of exclusion and is based on the signs and symptoms consistent with ROME III criteria, and the absence of signs indicative of other abdominal pathology.
Rajindrajith S, Devanarayana NM, Adhikari C, Pannala W, Benninga MA Constipation in children: an epidemiological study in Sri Lanka using Rome III criteria.
At baseline, the mean age was 38 years, 90% of patients were female, 55 had irritable bowel syndrome (IBS), 36 functional dyspepsia, and 9 had other unspecified functional nonspecific gastrointestinal symptoms by ROME III criteria.
Subjects fulfilling the Rome III criteria (9) for the diagnosis of IBS were invited to participate and, if agreeable, recruited by the investigators.